Apricus Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
Apricus Wealth's ABBV Position: Q2 2026 in Review
Apricus Wealth increased its AbbVie (ABBV) stake by 25% in Q2 2026, buying an estimated $1.15M and bringing the position to 26,234 shares worth $6.6M. The position accounts for 3.15% of the portfolio, ranked #1.
Apricus Wealth first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,621 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Apricus Wealth held 26,234 shares of AbbVie worth $6.6M as of Q2 2026.
- Apricus Wealth bought 5,330 AbbVie shares in Q2 2026, an estimated $1.15M.
- AbbVie made up 3.15% of Apricus Wealth's portfolio in Q2 2026, its #1 holding.
- Apricus Wealth first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 1,621 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Apricus Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.